Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced ...
The global pharmaceutical industry is at a critical inflection point. While the FDA Modernization Act 2.0 has cleared the ...
Two approaches to AI in preclinical drug discovery are diverging, from multi-thousand GPU systems to models with only a ...
The fourth edition reflects both the maturation of Generative AI and our deeper understanding of its practical application in discovery and investigations. Since the third edition, AI systems have ...
For R&D leaders evaluating AI investments, I’d offer one piece of advice: Before spending more on models, look hard at your ...
Organoids and engineered systems are transforming malaria research, improving drug discovery and understanding of Plasmodium ...
SHANGHAI, SHANGHAI, CHINA, April 30, 2026 /EINPresswire.com/ -- In today’s life sciences industry, moving a drug ...
The field of pharmacophore modeling has steadily emerged as a cornerstone in the rational design of kinase inhibitors. By abstracting the essential molecular features required for optimal binding to ...
The Electronic Discovery Reference Model (EDRM) is undergoing a remodel, as myriad data sources, growing ESI, and new technology is turning e-discovery into a non-linear, complex process. [Editor’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results